¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"oxygen affinity abnormality"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
¿µ¹® oxygen ÇÑ±Û »ê¼Ò
¼³¸í   
  Æó·Î µé¾î°¡ ¸ð¼¼Ç÷°üÀ» ÅëÇØ ÀûÇ÷±¸³»·Î µé¾î°£´Ù. ÀûÇ÷±¸³»ÀÇ Ç÷»ö¼ÒÀÇ ¿ªÇҷΠ½Åü³» ¸ðµç Á¶Á÷¼¼Æ÷¿¡ ÀüÇØÁö¸ç, ÀÎü´ë»çÀÛ¿ë¿¡ ÇʼöÀûÀΠ±âüÀÌ´Ù.
¿µ¹® developmental abnormality ÇÑ±Û ¹ß´ÞÀÌ»ó
¼³¸í   
  ¹ß´Þ°úÁ¤, Áï ¼öÅ·κÎÅÍ »çÃá±â³ª ¾î¸¥ÀÌ µÇ¾î ¼º¼÷ÀÌ µÉ ¶§±îÁö »çÀÌ¿¡ ¾î´À ½Ã±â¿¡¼­ »ý±â´Â ÀÌ»óÀÌ´Ù. ±×·¯³ª Á¼Àº Àǹ̷δ ¼öźÎÅÍ Ãâ»ý±îÁöÀÇ ±â°£¿¡ »ý±ä ÀÌ»ó Áï ¼±ÃµÀÌ»óÀ» ÀǹÌÇÑ´Ù. ¼±ÃµÀÌ»ó(congenital abnormality)°ú µ¿ÀǾî.
¿µ¹® chromosome abnormality ÇÑ±Û ¿°»öüÀÌ»ó
¼³¸í   
  ¿°»öüÀÇ ¼ö³ª ±¸Á¶ÀÇ ÀÌ»ó. ÀÌ»óÀÌ »ý±ä ¼¼Æ÷³ª °³Ã¼´Â À¯ÀüÀûÀΠÀÌ»óÀ» ÀÏÀ¸ÄÑ »ç¶÷ÀÇ °æ¿ì, ´Ù¿î ÁõÈıº-ÅͳʠÁõÈıº µûÀ§ÀÇ ¿©·¯ °¡Áö ÇüÅ·Π³ªÅ¸³­´Ù.
¿µ¹® abnormality, anomaly ÇÑ±Û ÀÌ»ó, ºñÁ¤»ó
¼³¸í   
  Á¤»óÀ» ¹þ¾î³­ ¼ºÁú È¤Àº »ç½Ç. anomaly, aberration µîµµ ÀÌ»ó »óŸ¦ ³ªÅ¸³»´Â °ÍÀÌÁö¸¸ abnormality°¡ °¡Àå ³ÐÀº ÀǹÌÀÇ ÀÌ»óÀÌ´Ù. anomaly´Â º¸Åë ¼±ÃµÀû ÀÌ»óÀ» ÀǹÌÇϸç, aberrationÀº ¸Ç ´«À¸·Î º¸ÀÌÁö ¾Ê´Â ÀÌ»óÀ» ÀǹÌÇϴ °æ¿ì°¡ ¸¹´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • affinity
    ģȭ·Â, ģȭ¼º
  • affinity chromatography
    ģȭũ·Î¸¶Åä±×·¡ÇÇ
  • affinity coefficient
    ģȭ°è¼ö
  • affinity constant
    ģȭ»ó¼ö
  • chemical affinity
    È­ÇÐģȭ·Â, È­ÇÐÀûģȭ¼º
  • electron affinity
    ÀüÀÚģȭ·Â
  • abnormality
    ÀÌ»ó, ºñÁ¤»ó
  • chromosomal abnormality
    ¿°»öüÀÌ»ó
  • developmental abnormality
    ¹ß´ÞÀÌ»ó
  • growth abnormality
    ¼ºÀåÀÌ»ó
  • motor abnormality
    ¿îµ¿ÀÌ»ó
  • metabolic abnormality
    ´ë»çÀÌ»ó
  • nailfold capillary abnormality
    ¼ÕÅéÁÖ¸§¸ð¼¼Ç÷°üÀÌ»ó
  • positional abnormality
    À§Ä¡ÀÌ»ó
  • arterial oxygen saturation
    µ¿¸ÆÇ÷»ê¼ÒÆ÷È­µµ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • affinity
    ģȭ·Â
  • abnormality
    ÀÌ»ó, ºñÁ¤»ó
  • chromosomal abnormality
    ¿°»öüÀÌ»ó
  • motor abnormality
    ¿îµ¿Àå¾Ö
  • positional abnormality
    À§Ä¡ÀÌ»ó
  • oxygen consumption
    »ê¼Ò¼Ò¸ð
  • oxygen content
    »ê¼ÒÇÔÀ¯·®
  • fraction in inspired oxygen
    ÈíÀÔ»ê¼Ò³óµµ
  • oxygen fraction in inspired air
    ÈíÀÔ»ê¼Ò³óµµ
  • oxygen
    »ê¼Ò
  • active oxygen
    Ȱµ¿»ê¼Ò, Ȱ¼º»ê¼Ò
  • hyperbaric oxygen
    °í¾Ð»ê¼Ò
  • saturation dissolved oxygen
    Æ÷È­¿ëÇØ»ê¼Ò·®
  • oxygen requirement
    »ê¼Ò¿ä±¸·®
  • arterial oxygen saturation
    µ¿¸ÆÇ÷»ê¼ÒÆ÷È­µµ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • affinity
    ģȭ·Â
  • affinity chromatography
    ģȭũ·Î¸¶Åä±×·¡ÇÇ
  • affinity coefficient
    ģȭ°è¼ö
  • affinity constant
    ģȭ»ó¼ö
  • chemical affinity
    È­ÇÐģȭ·Â, È­ÇÐÀûģȭ¼º
  • electron affinity
    ÀüÀÚģȭ·Â
  • vital affinity
    ¿µ¾çģȭ¼º, Ȱ·Âģȭ¼º
  • abnormality
    ÀÌ»ó, ºñÁ¤»ó
  • chromosome abnormality
    ¿°»öüÀÌ»ó
  • developmental abnormality
    ¹ß´ÞÀÌ»ó
  • growth abnormality
    ¼ºÀåÀÌ»ó
  • metabolic abnormality
    ´ë»çÀÌ»ó
  • motor abnormality
    ¿îµ¿Àå¾Ö
  • nailfold capillary abnormality
    ¼ÕÅéÁÖ¸§¸ð¼¼Ç÷°üÀÌ»ó
  • positional abnormality
    À§Ä¡ÀÌ»ó
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • altered oxygen affinity
    »ê¼Òģȭ¼º º¯¼º
  • abnormality
    ºñÁ¤»ó
  • abnormality by infection
    °¨¿°±âÇü
  • abnormality of cell interaction
    ¼¼Æ÷»óÈ£ÀÛ¿ëÀÌ»ó
  • abnormality of conduction
    ÀüµµÀÌ»ó.
  • abnormality of organ
    ±â°üÀÌ»ó
  • abnormality of tissue
    Á¶Á÷ÀÌ»ó
  • affinity
    ģȭ¼º
  • affinity
    ģȭ¼º(öÑûúàõ), ģȭ·Â(öÑûúæ³)
  • affinity
    ģȭ¼º(öÑûúàõ), ģȭ·Â(öÑûúÕô), °áÇÕ¼º.
  • affinity
    ģȭ·Â, ģȭ¼º
  • affinity chromatography
    ģȭ(öÑûú) Å©·Î¸¶Åä±×¶óÇÇ.
  • affinity chromatography
    ģȭ¼º Å©·Î¸¶Åä±×·¡ÇÇ
  • affinity coefficient
    ģȭ°è¼ö(öÑûúÌõâ¦)
  • affinity constant
    ģȭ»ó¼ö(öÑûúßÈâ¦)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • oxygen affinity abnormality
    »ê¼Òģȭ¼º( öÑûúàõ) ÀÌ»ó
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • altered oxygen affinity
    »ê¼Òģȭ¼º º¯¼º
  • oxygen affinity
    »ê¼Òģȭ¼º(ß«áÈöÑûúàõ).
  • affinity
    ģȭ¼º(öÑûúàõ), ģȭ·Â(öÑûúæ³)
  • affinity
    ģȭ·Â, ģȭ¼º
  • affinity
    ģȭ¼º(öÑûúàõ), ģȭ·Â(öÑûúÕô), °áÇÕ¼º.
  • affinity
    ģȭ¼º
  • affinity chromatography
    ģȭ(öÑûú) Å©·Î¸¶Åä±×¶óÇÇ.
  • affinity chromatography
    ģȭ¼º Å©·Î¸¶Åä±×·¡ÇÇ
  • affinity coefficient
    ģȭ°è¼ö(öÑûúÌõâ¦)
  • affinity constant
    ģȭ»ó¼ö(öÑûúßÈâ¦)
  • binding affinity
    °áÇÕģȭ¼º(Ì¿ùêöÑûúàõ)
  • chemical affinity
    È­ÇÐģȭ·Â(¡­öÑûúæ³), È­ÇÐÀû ģȭ¼º.
  • electron affinity
    ÀüÀÚģȭ·Â(¡­öÑûúæ³).
  • intrinsic affinity
    º»Å¼º ģȭ·Â, ³»À缺 ģȭ·Â
  • vital affinity
    ¿µ¾çģȭ¼º(ç½å×öÑûùàõ).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Abnormality by infection
    °¨¿°±âÇü
    [¿¾ ¿ë¾î] °¨¿°ºñÁ¤»ó
  • Abnormality of organ
    ±â°üÀÌ»ó
    [¿¾ ¿ë¾î] ±â°üÀÌ»ó
  • Abnormality
    ºñÁ¤»ó
    [¿¾ ¿ë¾î] ºñÁ¤»ó
  • Growth abnormality
    ¼ºÀåÀÌ»ó
    [¿¾ ¿ë¾î] ¼ºÀåÀÌ»ó
  • Abnormality of tissue
    Á¶Á÷ÀÌ»ó
    [¿¾ ¿ë¾î] Á¶Á÷ÀÌ»ó
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • affinity
    ģȭ·Â(öÑûúÕô)
  • affinity chromatography
    ģȭ(öÑûú)Å©·Î¸¶Åä±×·¡ÇÇ
  • affinity constant
    ģȭ»ó¼ö(öÑûúßÈâ¦)
  • affinity electrophoresis
    ģȭÀü±â¿µµ¿ (öÑûúï³Ñ¨ç¶ÔÑ)
  • affinity elution
    ģȭ¿ëÃâ(öÑûúéÁõó)
  • affinity labelling
    ģȭǥÁö(öÑûúøöãÛ)
  • affinity partitioning
    ģȭºÐ¹è(öÑûúÝÂÛÕ)
  • affinity ratio
    ģȭºñ(öÑûúÝï)
  • average affinity
    Æò±Õģȭ·Â (øÁгöÑûúÕô)
  • cell affinity
    ¼¼Æ÷ģȭ(á¬øàöÑûú)
  • electron affinity
    "ÀüÀÚ Ä£È­¼º(ï³í­öÑûúàõ)(µµ,Óø)"
  • filter affinity transfer
    °Å¸£°Ô ģȭÀüÀÌ(öÑûúï®ì¹)
  • magnetic affinity chromatography
    ÀÚ±âģȭ(í¸ÐïöÑûú) Å©·Î¸¶Åä±×·¡ÇÇ
  • proton affinity
    ¾ç¼ºÀÚ Ä£È­µµ(öÑûúÓø)
  • biochemical oxygen demand
    »ýÈ­ÇÐÀû(ßæûùùÊîÜ) »ê¼Ò¿ä±¸·®(ß«áÈé©Ï´Õá)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • affinity
    ģȭ¼º, ģȭ·Â
  • oxygen
    »ê¼Ò
  • oxygen free radical
    »ê¼ÒÀÚÀ¯±â
  • abnormality
    ÀÌ»ó, ÀÌ»ó¼º
  • developmental abnormality
    ¹ßÀ°ÀÌ»ó
  • growth abnormality
    ¹ßÀ°ÀÌ»ó
  • proton flow abnormality
    ¾çÀÚÀ¯µ¿ÀÌ»ó
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
EA early antigen; educational age; egg albumin; electric affinity; electrical activity; electroacupunct...
E0 electric affinity
EAQ eudismic affinity quotient
HAChT high affinity choline transport
HALC high affinity-low capacity
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
SCIWORA Spinal Cord Injury Without Radiographic Abnormality
WMA Wall motion abnormality
ACE Affinity capillary electrophoresis
AC Affinity chromatography
3H High affinity
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • oxygen affinity
    »ê¼Ò ģȭ¼º
  • affinity
    ģȭ¼º, ģȭ·Â
    1. °íÀ¯ÇÑ À¯»ç¼ºÀ̳ª À¯¿¬ °ü°è. 2. Ưº°ÇÑ ¿ä¼Ò, ±â°ü, ±¸Á¶¹°¿¡ ´ëÇÑ Æ¯º°ÇÑ Ä£È­·Â. 3. È­ÇÐÀû ģȭ·Â. ºÐÀÚÀÇ ¿ø¼ÒµéÀ» °áÇÕ½ÃŰ´Â Èû. È­ÇÐÀû ¹ÝÀÀ¿¡ ÀÇÇØ °áÇÕÇÏ·Á´Â °æÇâ. 4. º¹ÇÕüÀÇ ÇØ¸®»ó¼ö¿¡ ÀÇÇØ ÃøÁ¤µÈ µÎ ¹°Áú »çÀÌÀÇ ºñ°øÀ¯ È­ÇÐÀû °áÇÕ·Â. 5. ¸é¿ªÇп¡¼­, ´ÜÀÏ Ç׿ø °áÇÕ ºÎÀ§¿Í ´ÜÀÏ Ç׿ø °áÁ¤ ÀÎÀÚ°£ÀÇ »óÈ£ÀÛ¿ë·ÂÀÇ ¿­¿ªÇÐÀû Ç¥Çö.
  • affinity chromatography
    ģȭ¼º Å©·Î¸¶Åä±×·¡ÇÇ
    ģȭ¼ºÀ» ÀÌ¿ëÇÏ¿© ƯÁ¤ ¹°ÁúÀ» ¿ë¾× ¼Ó¿¡¼­ ºÐ¸®ÇÏ´Â Å©·Î¸¶Åä±×·¡ÇÇ. Ç׿ø-Ç×ü, ±âÁú-È¿¼Ò, µ¶¼Ò-µ¶¼Ò°¡ °áÇÕÇÏ´Â ¼ö¿ëü, lectin-lectin °áÇÕ¼ö¿ëü µîÀÇ ÇÑÆíÀ» ºÒ¿ë¼ºÀÇ ´ãü¿¡ °øÀ¯°áÇÕ½Ã۰í À̰Ͱú ºÐ¸®ÇÏ°í ½ÍÀº ¿ë¾×À» ¹ÝÀÀ½ÃÄÑ Àß ¼¼Á¤Çϸé ģȭ¼ºÀÌ ³ôÀº ¹°Áú¸¸ÀÌ °áÇÕÇϹǷΠ½Å¼ÓÇÏ°Ô ¿øÇÏ´Â ¹°ÁúÀ» È¿À²ÀûÀ¸·Î ²ø¾î³¾ ¼ö ÀÖ´Ù.
  • affinity constant
    ģȭ »ó¼ö
  • chemical affinity
    È­ÇРģȭ·Â, È­ÇÐÀû ģȭ¼º
  • electron affinity
    ÀüÀÚ Ä£È­·Â
    ¿øÀÚ°¡ ÀüÀÚ 1°³¿Í °áÇÕÇÒ ¶§¿¡ ¹æÃâÇÏ´Â ¿¡³ÊÁö.
  • high-affinity agonist
    °íģȭ¼º ÀÛ¿ë ¹°Áú
  • morbid affinity
    Áúº´ ģȭ¼º
  • vital affinity
    ¿µ¾ç ģȭ¼º
  • abnormality
    ÀÌ»ó¼º, ºñÁ¤»ó, ÀÌ»ó, ±âÇü
    µ¿ÀǾî=abnormity. 1. ºñÁ¤»óÀûÀÎ ¼ºÁúÀ̳ª »ç½Ç.
  • abnormality of cell interaction
    ¼¼Æ÷ »óÈ£ÀÛ¿ë ÀÌ»ó
    ¼¼Æ÷ »çÀÌ¿¡ ÀϾ´Â ÀÛ¿ëÀÌ ºñÁ¤»óÀûÀÎ °Í.
  • abnormality of organ
    ±â°ü ÀÌ»ó
    Æó, ½ÉÀå, °£Àå, ÃéÀå, ½ÅÀå µî°ú °°Àº ±â°üÀÇ Çüųª ¼ö°¡ Á¤»óÀûÀÌÁö ¾ÊÀº »óÅÂ.
  • autosomal abnormality
    »ó¿°»öü ÀÌ»ó
  • behavioral abnormality
    Çൿ ÀÌ»ó
    µ¿ÀǾî=behavioral disorder.
  • chromosome abnormality
    ¿°»öü ÀÌ»ó
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
oxygen affinity anoxia Anoxia due to inability of haemoglobin to release oxygen.
(05 Mar 2000)
oxygen affinity hypoxia Hypoxia due to reduced ability of haemoglobin to release oxygen.
(05 Mar 2000)
abnormality 1. The state or quality of being abnormal.
2. An anomaly, deformity, malformation, impairment, or dysfunction.
(05 Mar 2000)
snowman abnormality A radiographic appearance associated with total anomalous drainage of the pulmonary venous circulation into enlarged right and anomalous left venae cavae, that produces a globular density above the heart; the silhouette suggests the figure 8.
Synonym: snowman abnormality.
(05 Mar 2000)
karyotypic abnormality Abnormality in the number form or structure of chromosomes. Particular abnormalities are associated with particular sub- types of leukaemia.
(27 Sep 1997)
figure-of-8 abnormality A radiographic appearance associated with total anomalous drainage of the pulmonary venous circulation into enlarged right and anomalous left venae cavae, that produces a globular density above the heart; the silhouette suggests the figure 8.
Synonym: snowman abnormality.
(05 Mar 2000)
affinity 1. An inherent likeness or relationship.
2. A special attraction for a specific element, organ or structure.
3. <chemistry> The force that binds atoms in molecules, the tendency of substances to combine by chemical reaction.
4. The strength of noncovalent chemical binding between two substances as measured by the dissociation constant of the complex.
5. <immunology> A thermodynamic expression of the strength of interaction between a single antigen binding site and a single antigenic determinant (and thus of the stereochemical compatibility between them), most accurately applied to interactions among simple, uniform antigenic determinants such as haptens. Expressed as the association constant (K litres mole 1), which, owing to the heterogeneity of affinities in a population of antibody molecules of a given specificity, actually represents an average value (mean intrinsic association constant).
6. <chemistry> The reciprocal of the dissociation constant.
Origin: L. Affinitas = relationship
(06 Oct 1997)
affinity adsorbent <immunology> A support matrix coated with an affinity antibodies.
(06 May 1997)
affinity antibody The measure of the interaction between molecules such as a receptor and its ligand. This interaction is reversible.
(05 Mar 2000)
affinity chromatography <investigation> A technique of analytical chemistry used to separate and purify a biological molecule from a mixture, based on the attraction of the molecule of interest to a particular ligand which has been previously attached to a solid, inert substance.
The mixture is passed through a column containing the ligand attached to the stationary substance, so that the molecule of interest stays within the column while the rest of the mixture continues through to the end. Then, a different chemical is flushed through the column to detach the molecule from the ligand and bring it out separately from the rest of the mixture.
(09 Feb 1998)
affinity column <investigation> A technique of analytical chemistry used to separate and purify a biological molecule from a mixture, based on the attraction of the molecule of interest to a particular ligand which has been previously attached to a solid, inert substance.
The mixture is passed through a column containing the ligand attached to the stationary substance, so that the molecule of interest stays within the column while the rest of the mixture continues through to the end. Then, a different chemical is flushed through the column to detach the molecule from the ligand and bring it out separately from the rest of the mixture.
(09 Feb 1998)
affinity labeling <technique> A method for tagging molecules, such as enzymes, so that they can be more easily detected and studied. The method works by substituting a synthetic substance which is similar to the substance that the enzyme normally bonds with.
(09 Feb 1998)
affinity labels Analogs of those substrates or compounds which bind naturally at the active sites of proteins, enzymes, antibodies, steroids, or physiological receptors. These analogs form a stable covalent bond at the binding site, thereby acting as inhibitors of the proteins or steroids.
(12 Dec 1998)
affinity tag <biochemistry, molecular biology> A short amino acid sequence, usually engineered onto the N- or C-terminus of a protein, to make its purification easier.
(14 Nov 1997)
antibody affinity A measure of the binding strength between antibody and a simple hapten or antigen determinant. It depends on the closeness of stereochemical fit between antibody combining sites and antigen determinants, on the size of the area of contact between them, and on the distribution of charged and hydrophobic groups. It includes the concept of "avidity," which refers to the strength of the antigen-antibody bond after formation of reversible complexes.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • abnormality
    ºñÁ¤»ó
  • abnormality
    ÀÌ»ó;º¯Ä¢;º´½Å;ºÒ±¸
  • affinity
    À¯»ç
  • affinity
    ģô(°ü°è);(Ÿ°í³­)Ãë¹Ì;±âÈ£(for);À¯»ç;Ä£±Ù¼º;±Ù¿¬
  • elective affinity
    (È­)(¼±ÅÃ)ģȭ·Â
  • electron affinity
    (¹°)ÀüÀÚ Ä£È­·Â
  • heavy oxygen
    Áß»ê¼Ò
  • hyperbaric oxygen therapy
    °í³óµµ »ê¼Ò ¿ä¹ý(ÀÏ»êȭź¼Ò Áßµ¶,³úÁ¹Áõ,´Ù¹ß¼º °æÈ­Áõ µî¿¡ »ç¿ëµÊ)
  • oxygen
    »ê¼Ò
  • oxygen debt
    »ê¼Òä
  • oxygen mask
    »ê¼Ò ¸¶½ºÅ©
  • oxygen tent
    »ê¼Ò ÅÙÆ®
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á